chr2-232531450-C-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS1_SupportingBS2

The NM_000751.3(CHRND):​c.919C>T​(p.Pro307Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00148 in 1,613,976 control chromosomes in the GnomAD database, including 3 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P307L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00083 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0015 ( 2 hom. )

Consequence

CHRND
NM_000751.3 missense

Scores

12
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:9B:2

Conservation

PhyloP100: 6.09

Publications

9 publications found
Variant links:
Genes affected
CHRND (HGNC:1965): (cholinergic receptor nicotinic delta subunit) The acetylcholine receptor of muscle has 5 subunits of 4 different types: 2 alpha and 1 each of beta, gamma and delta subunits. After acetylcholine binding, the receptor undergoes an extensive conformation change that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. Defects in this gene are a cause of multiple pterygium syndrome lethal type (MUPSL), congenital myasthenic syndrome slow-channel type (SCCMS), and congenital myasthenic syndrome fast-channel type (FCCMS). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2015]
CHRND Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 3A
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • congenital myasthenic syndrome 3B
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • congenital myasthenic syndrome 3C
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000834 (127/152234) while in subpopulation NFE AF = 0.00134 (91/68000). AF 95% confidence interval is 0.00112. There are 1 homozygotes in GnomAd4. There are 61 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 2 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000751.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRND
NM_000751.3
MANE Select
c.919C>Tp.Pro307Ser
missense
Exon 8 of 12NP_000742.1Q07001-1
CHRND
NM_001256657.2
c.874C>Tp.Pro292Ser
missense
Exon 7 of 11NP_001243586.1Q07001-2
CHRND
NM_001311196.2
c.616C>Tp.Pro206Ser
missense
Exon 8 of 12NP_001298125.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRND
ENST00000258385.8
TSL:1 MANE Select
c.919C>Tp.Pro307Ser
missense
Exon 8 of 12ENSP00000258385.3Q07001-1
CHRND
ENST00000543200.5
TSL:2
c.874C>Tp.Pro292Ser
missense
Exon 7 of 11ENSP00000438380.1Q07001-2
CHRND
ENST00000955151.1
c.718C>Tp.Pro240Ser
missense
Exon 7 of 11ENSP00000625210.1

Frequencies

GnomAD3 genomes
AF:
0.000835
AC:
127
AN:
152116
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00134
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00103
AC:
259
AN:
251440
AF XY:
0.000876
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.00208
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00149
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.00155
AC:
2262
AN:
1461742
Hom.:
2
Cov.:
32
AF XY:
0.00142
AC XY:
1035
AN XY:
727180
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33480
American (AMR)
AF:
0.00233
AC:
104
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53350
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.00187
AC:
2078
AN:
1111938
Other (OTH)
AF:
0.00118
AC:
71
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
126
252
377
503
629
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000834
AC:
127
AN:
152234
Hom.:
1
Cov.:
31
AF XY:
0.000819
AC XY:
61
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41538
American (AMR)
AF:
0.00131
AC:
20
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00134
AC:
91
AN:
68000
Other (OTH)
AF:
0.00189
AC:
4
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00129
Hom.:
2
Bravo
AF:
0.00116
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00116
AC:
10
ExAC
AF:
0.000865
AC:
105
EpiCase
AF:
0.000927
EpiControl
AF:
0.00207

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
6
1
not provided (7)
-
1
1
Lethal multiple pterygium syndrome (2)
-
1
-
Congenital myasthenic syndrome (1)
-
1
-
Lethal multiple pterygium syndrome;C4225370:Congenital myasthenic syndrome 3C;C4225371:Congenital myasthenic syndrome 3B;C4225372:Congenital myasthenic syndrome 3A (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.90
BayesDel_addAF
Pathogenic
0.21
D
BayesDel_noAF
Pathogenic
0.53
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.78
D
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.94
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.95
D
M_CAP
Pathogenic
0.33
D
MetaRNN
Uncertain
0.71
D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Pathogenic
4.0
H
PhyloP100
6.1
PrimateAI
Uncertain
0.62
T
PROVEAN
Pathogenic
-7.8
D
REVEL
Pathogenic
0.87
Sift
Uncertain
0.010
D
Sift4G
Uncertain
0.0050
D
Polyphen
1.0
D
Vest4
0.90
MVP
1.0
MPC
0.88
ClinPred
0.79
D
GERP RS
6.1
Varity_R
0.84
gMVP
0.83
Mutation Taster
=26/74
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142063328; hg19: chr2-233396160; API